The DOI matches its Crossref record; 297 of the 298 references it cites were found in a registry or an index.
Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care
Open accessAbstract
Endometriosis management seems to be influenced by outcome-independent biomedical, pharmacological, and technological developments. The propensity towards doing more affects several aspects of care, sometimes translating into proposals that are not based on sound epidemiological principles and robust evidence. Different stakeholders share the interest for doing more testing and using novel and costly drugs or devices in patients with endometriosis. Although some women may benefit from such an approach, the majority do not, and some may be harmed. Moreover, an uncontrolled increase in expenditures for endometriosis management without demonstrated and proportional health benefits would waste the finite resources of national health care services and would risk cost-related non-adherence. Cost-effectiveness analyses should be systematically pre-planned in future trials on endometriosis, and the concept of "value" of medical interventions should guide investigators and health care policymakers. Reducing low-value care, financial toxicity, and the burden of treatment is respectful not only of endometriosis patients, but also of the entire society. Whenever possible, long-term therapeutic strategies should be tailored to each woman's needs, and high-value tests and treatments should be chosen based on her priorities and preferences. Moreover, listening to patients, understanding their concerns, avoiding disease labelling, explaining plainly what is known and what is unknown, and giving constant reassurance and encouragement may be exceedingly important for the successful management of endometriosis and may change the patient's perception of her clinical condition. Physician empathy has no untoward effects, does not cause harms, and may determine whether a woman successfully copes or desperately struggles with her disease during reproductive life.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2 retracted
Robotic surgery for benign gynaecological disease
Liu, H., Lu, D., Wang, L., Shi, G., Song, H., & Clarke, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008978.pub2 · Cited by 122
RetractedRobotic surgery for benign gynaecological disease
Liu, H., Lu, D., Wang, L., Shi, G., Song, H., & Clarke, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008978 · Cited by 59
RetractedPorter, M. E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011024 · Cited by 5,084
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563
A comparison of observational studies and randomized, controlled trials.
Benson, K., & Hartz, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422506 · Cited by 2,347
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Self-citationScope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
New Technology and Health Care Costs — The Case of Robot-Assisted Surgery
Barbash, G. I., & Glied, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006602 · Cited by 993
Research works printed but not linked: 1
- Vercellini, 2017, The ominous combination of severe endometriosis, in vitro fertilization and placenta previa, BJOG
Cited by
Sorted by citations
Medical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
Self-citationDonnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051085 · Cited by 182
Vercellini, P., Viganò, P., Buggio, L., Makieva, S., Scarfone, G., Cribiù, F. M., Parazzini, F., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.017 · Cited by 81
Self-citationWhen more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement
Club, E. E. T. I., Alio, L., Angioni, S., Arena, S., Bartiromo, L., Bergamini, V, Berlanda, N., Bonin, C., Busacca, M., Candiani, M., et al. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoz009 · Cited by 64
Self-citationMedical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence
Barbàra, G., Buggio, L., Facchin, F., & Vercellini, P. (2021) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2021.729601 · Cited by 60
Self-citation
Metadata
- Authors
- Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E.
- Affiliations
- University of Milan (IT)
- Università Cattolica del Sacro Cuore (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Corresponding author
- Vercellini, Paolo
- ORCID
- Venue
- Journal of Obstetrics and Gynaecology Canada
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 40
- Issue
- 6
- Pages
- 726-749.e10
- ISSN
- 1701-2163 (ISSN-L)
- OpenAlex
- W2761947111
- Cited by
- 36
- References
- 298
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 6 · 2020: 1 · 2019: 3 · 2018: 6
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Journal of Obstetrics and Gynaecology Canada (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Ferring
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- EMD Serono (5x1000)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- endometriosis, low-value care, cost-effectiveness, value-based care, financial toxicity, overuse of diagnostic testing, patient preferences, patient-centered care, physician empathy, health care expenditure, cost-related nonadherence
- MeSH terms
- Adolescent, Cost-Benefit Analysis, Costs and Cost Analysis, Endometriosis, Female, Fertilization in Vitro, Health Priorities, Humans, Infertility, Female, Menopause, Ovarian Neoplasms, Ovariectomy, Conflict of Interest, Treatment Outcome, Hormone Replacement Therapy, Patient Preference, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review